Chronic graft‐versus‐host disease (cGvHD) remains the most important long‐term
complication of allogeneic hematopoietic cell transplantation (allo‐HCT), but the field has …

Over the last decade, our understanding of the pathophysiology of chronic graft-versus-host
disease (cGVHD) has improved considerably. In this spotlight, we discuss emerging insights …

Follicular helper T (Tfh) cells have been implicated in controlling rejection after allogeneic
kidney transplantation, but the precise subsets, origins, and functions of Tfh cells in this …

Allogeneic hematopoietic stem cell transplantation (alloHCT) is the definitive therapy for
numerous otherwise incurable hematologic malignancies and non-malignant diseases. The …

Chronic Graft-versus-Host Disease is a life-threatening inflammatory condition that affects
many patients after allogeneic hematopoietic stem cell transplantation. Although we have …

Herein we review current practice regarding the management of chronic graft-vs.-host
disease (cGvHD) in paediatric patients after allogeneic haematopoietic stem cell …

Systemic sclerosis is an autoimmune disease characterized by excessive dermal fibrosis
with progression to internal organs, vascular impairment and immune dysregulation …

Introduction Chronic graft-versus-host disease (cGVHD) is a complication of allogeneic
hematopoietic cell transplantation (allo-HCT) and is the main cause of late non-relapse …

Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is associated
with an increased risk of graft-versus-host disease (GvHD), a strong prognostic predictor of …

Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic
hematopoietic cell transplantation and a leading cause of long-term morbidity, nonrelapse …